Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection.
Meriglier E, Rivoisy C, Hessamfar M, Bernard N, Aureau I, Lapoirie J, Contis A, Sacher F, Sacristan B, Lahouati M, Pedeboscq S, Vandenhende MA, Bouchet S, Bonnet F.
Meriglier E, et al. Among authors: lahouati m.
J Antimicrob Chemother. 2021 Jan 19;76(2):482-486. doi: 10.1093/jac/dkaa441.
J Antimicrob Chemother. 2021.
PMID: 33221868
Free PMC article.